Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease.
Cash DM, Morgan KE, O'Connor A, Veale TD, Malone IB, Poole T, Benzinger TL, Gordon BA, Ibanez L, Li Y, Llibre-Guerra JJ, McDade E, Wang G, Chhatwal JP, Day GS, Huey E, Jucker M, Levin J, Niimi Y, Noble JM, Roh JH, Sánchez-Valle R, Schofield PR, Bateman RJ, Frost C, Fox NC; Dominantly Inherited Alzheimer Network (DIAN).
Cash DM, et al. Among authors: noble jm.
medRxiv [Preprint]. 2024 Nov 16:2024.11.12.24316919. doi: 10.1101/2024.11.12.24316919.
medRxiv. 2024.
PMID: 39606328
Free PMC article.
Preprint.